University Clinical Centre of Kragujevac

Kragujevac 34000

3 studies enrolling now · 5 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Multiple Sclerosis (MS) Primary Progressive, Primary Immune Thrombocytopenia (ITP), Relapsing-remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis — Recruiting now
• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis — Recruiting now
• A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia — Recruiting now
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling